N-Methy1-N-(3-{[2-(2-oxo-2,3-dihydro-1H-indol-5-ylamino)-5-trifluoromethy1-pyrimidin-4-ylamino]-methy1}-pyridin-2-yl)-methanesulfonamide benzenesulfonate

ID: ALA2430359

Cas Number: 939791-38-5

PubChem CID: 16118986

Product Number: P129811, Order Now?

Max Phase: Preclinical

Molecular Formula: C27H26F3N7O6S2

Molecular Weight: 507.50

Molecule Type: Small molecule

Names and Identifiers

Canonical SMILES:  CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O.O=S(=O)(O)c1ccccc1

Standard InChI:  InChI=1S/C21H20F3N7O3S.C6H6O3S/c1-31(35(2,33)34)19-12(4-3-7-25-19)10-26-18-15(21(22,23)24)11-27-20(30-18)28-14-5-6-16-13(8-14)9-17(32)29-16;7-10(8,9)6-4-2-1-3-5-6/h3-8,11H,9-10H2,1-2H3,(H,29,32)(H2,26,27,28,30);1-5H,(H,7,8,9)

Standard InChI Key:  LKLWTLXTOVZFAE-UHFFFAOYSA-N

Molfile:  

     RDKit          2D

 45 48  0  0  0  0  0  0  0  0999 V2000
   14.6090   -8.8240    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   14.6078   -9.6435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3159  -10.0525    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0255   -9.6430    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   16.0227   -8.8204    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3141   -8.4151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   15.3116   -7.5979    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   16.0181   -7.1872    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.5155   -7.8046    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   14.7260   -7.0122    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    8.1994   -6.1289    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.1982   -6.9484    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9063   -7.3574    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    9.6159   -6.9480    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.6131   -6.1253    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9045   -5.7200    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   10.3193   -5.7140    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0285   -6.1200    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   10.3162   -4.8969    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   11.0238   -5.2994    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
    7.4902   -7.3565    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    7.4896   -8.1737    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7814   -8.5801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1987   -9.3941    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.1962   -8.5790    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4883   -9.8066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7822   -9.4013    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.1785   -9.9477    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.5117  -10.6907    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3211  -10.6033    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.1050  -11.3995    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   10.3243   -7.3554    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   10.3256   -8.1726    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0339   -8.5801    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.0306   -9.3947    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7381   -9.8021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4462   -9.3923    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   12.4423   -8.5709    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   11.7342   -8.1672    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.7282   -7.3500    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   12.4329   -6.9362    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
   11.0175   -6.9466    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   13.1436   -7.3396    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   11.8493   -6.3518    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   12.8357   -6.2239    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  4  2  0
  4  5  1  0
  5  6  2  0
  6  1  1  0
  6  7  1  0
  7  8  1  0
  7  9  2  0
  7 10  2  0
 11 12  2  0
 12 13  1  0
 13 14  2  0
 14 15  1  0
 15 16  2  0
 16 11  1  0
 15 17  1  0
 17 18  1  0
 17 19  1  0
 17 20  1  0
 12 21  1  0
 21 22  1  0
 22 23  2  0
 23 27  1  0
 26 24  1  0
 24 25  2  0
 25 22  1  0
 26 27  2  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 26  1  0
 29 31  2  0
 14 32  1  0
 32 33  1  0
 33 34  1  0
 34 35  2  0
 35 36  1  0
 36 37  2  0
 37 38  1  0
 38 39  2  0
 39 34  1  0
 39 40  1  0
 40 41  1  0
 40 42  1  0
 41 43  1  0
 41 44  2  0
 41 45  2  0
M  END

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type: Small molecule

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 507.50

Molecular Weight (Monoisotopic): 507.1300

AlogP: 3.14

#Rotatable Bonds: 7

Polar Surface Area: 129.21

Molecular Species: NEUTRAL

HBA: 8

HBD: 3

#RO5 Violations: 1

HBA (Lipinski): 10

HBD (Lipinski): 3

#RO5 Violations (Lipinski): 1

CX Acidic pKa: 12.34

CX Basic pKa: 4.26

CX LogP: 1.91

CX LogD: 1.91

Aromatic Rings: 3

Heavy Atoms: 35

QED Weighted: 0.44

Np Likeness Score: -1.59

References

1. Lu X, Zhao L, Xue T, Zhang H.  (2013)  Design of novel focal adhesion kinase inhibitors using 3D-QSAR and molecular docking,  [10.1007/s00044-013-0768-0]

2. Bernhard Ellinger, Denisa Bojkova, Andrea Zaliani, Jindrich Cinatl, Carsten Claussen, Sandra Westhaus, Jeanette Reinshagen, Maria Kuzikov, Markus Wolf, Gerd Geisslinger, Philip Gribbon, Sandra Ciesek.  (2020)  Identification of inhibitors of SARS-CoV-2 in-vitro cellular toxicity in human (Caco-2) cells using a large scale drug repurposing collection,  [10.21203/rs.3.rs-23951/v1]

3. Choi MJ, Roh EJ, Hur W, Lee SH, Sim T, Oh CH, Lee SH, Kim JS, Yoo KH..  (2018)  Design, synthesis, and biological evaluation of novel aminopyrimidinylisoindolines as AXL kinase inhibitors.,  28  (23-24): [PMID:30340900] [10.1016/j.bmcl.2018.10.013]

4. Maria Kuzikov, Elisa Costanzi, Jeanette Reinshagen, Francesca Esposito, Laura Vangeel, Markus Wolf, Bernhard Ellinger, Carsten Claussen, Gerd Geisslinger, Angela Corona, Daniela Iaconis, Carmine Talarico, Candida Manelfi, Rolando Cannalire, Giulia Rossetti, Jonas Gossen, Simone Albani, Francesco Musiani, Katja Herzog, Yang Ye, Barbara Giabbai, Nicola Demitri, Dirk Jochmans, Steven De Jonghe, Jasper Rymenants, Vincenzo Summa, Enzo Tramontano, Andrea R. Beccari, Pieter Leyssen, Paola Storici, Johan Neyts, Philip Gribbon, and Andrea Zaliani.  (2020)  Identification of inhibitors of SARS-Cov2 M-Pro enzymatic activity using a small molecule repurposing screen,  [10.6019/CHEMBL4495564]

5. Andrea Zaliani, Laura Vangeel, Jeanette Reinshagen, Daniela Iaconis, Maria Kuzikov, Oliver Keminer, Markus Wolf, Bernhard Ellinger, Francesca Esposito, Angela Corona, Enzo Tramontano, Candida Manelfi, Katja Herzog, Dirk Jochmans, Steven De Jonghe, Winston Chiu, Thibault Francken, Joost Schepers, Caroline Collard, Kayvan Abbasi, Carsten Claussen , Vincenzo Summa, Andrea R. Beccari, Johan Neyts, Philip Gribbon and Pieter Leyssen.  (2020)  Cytopathic SARS-Cov2 screening on VERO-E6 cells in a large repurposing effort,  [10.6019/CHEMBL4495565]

6. Gao H,Wu Y,Sun Y,Yang Y,Zhou G,Rao Y.  (2020)  Design, Synthesis, and Evaluation of Highly Potent FAK-Targeting PROTACs.,  11  (10): [PMID:33062164] [10.1021/acsmedchemlett.9b00372]

Source

Source(2):

• Scientific Literature
• SARS-CoV-2 Screening Data 2020-21